<DOC>
	<DOCNO>NCT00910988</DOCNO>
	<brief_summary>Primary Aim : To test acute effect olanzapine ziprasidone administration , comparison placebo , insulin sensitivity antipsychotic-naïve healthy young men , measure whole-body dextrose infusion rate ( mg/kg/min ) , hepatic glucose production ( glucose rate appearance [ Ra ] ) , primarily muscle glucose utilization ( glucose rate disappearance [ Rd ] ) , adipose tissue relate free fatty acid production ( glycerol rate appearance [ Ra ] ) . We hypothesize olanzapine , ziprasidone , result acute decrease insulin sensitivity . Secondary Aim : To test acute effect olanzapine ziprasidone insulin signal pathway antipsychotic naïve healthy young men . We hypothesize olanzapine , ziprasidone , result acute alteration insulin signal .</brief_summary>
	<brief_title>Healthy Volunteers Study Effects Olanzapine Ziprasidone</brief_title>
	<detailed_description>See brief description</detailed_description>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Males age 1845 year BMI approximately ≥ 25 &lt; 35 insulin approximately ≥ 15 µU/ml triglyceride approximately ≥ 130 mg/dl Any DSMIV Axis I diagnosis prisoner serious medical disorder ( i.e . metabolic disease , type 1 2 diabetes mellitus , endocrine disease , coagulopathy , clinically significant anemia , acute infection ) take prescription medication nonsedentary lifestyle &gt; 3 hour exercise per week</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>healthy</keyword>
	<keyword>sedentary</keyword>
	<keyword>men</keyword>
	<keyword>acute effect antipsychotic</keyword>
	<keyword>blood sugar</keyword>
	<keyword>insulin sensitivity</keyword>
</DOC>